Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Oct 1;13(5):879-881.
doi: 10.21037/hbsn-24-445. Epub 2024 Sep 26.

Getting persuasive about the non-invasive: assessing liver fibrosis in practice-without a biopsy

Nida Ansari  1 , Patrick Twohig  2
Affiliations
Editorial

Getting persuasive about the non-invasive: assessing liver fibrosis in practice-without a biopsy

Nida Ansari et al. Hepatobiliary Surg Nutr. .
No abstract available

Keywords: Hepatic fibrosis; biomarker; cirrhosis; liver biopsy.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: Both authors have completed the ICMJE uniform disclosure form (available at https://hbsn.amegroups.com/article/view/10.21037/hbsn-24-445/coif). The authors have no conflicts of interest to declare.

Comment on

References

    1. Centers for Disease Control and Prevention, National Center for Health Statistics. National Vital Statistics System, Mortality 2018-2022 on CDC WONDER Online Database, released in 2024. Data are from the Multiple Cause of Death Files, 2018-2022, as compiled from data provided by the 57 vital statistics jurisdictions through the Vital Statistics Cooperative Program. [accessed at Jul 26, 2024]. Available online: http://wonder.cdc.gov/ucd-icd10-expanded.html
    1. Sterling RK, Duarte-Rojo A, Patel K, et al. AASLD Practice Guideline on imaging-based noninvasive liver disease assessment of hepatic fibrosis and steatosis. Hepatology 2024. [Epub ahead of print]. doi:. 10.1097/HEP.0000000000000843 - DOI - PubMed
    1. Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology 2018;67:328-57. 10.1002/hep.29367 - DOI - PubMed
    1. Paik JM, Kabbara K, Eberly KE, et al. Global burden of NAFLD and chronic liver disease among adolescents and young adults. Hepatology 2022;75:1204-17. 10.1002/hep.32228 - DOI - PubMed
    1. Fierbinteanu Braticevici C, Papacocea R, Tribus LC, et al. Can we replace liver biopsy with non-invasive procedures? In: Takahashi H. editor. Liver Biopsy. IntechOpen 2011. doi: 10.5772/19527. 10.5772/19527 - DOI